Comparison of Active and Passive Perioperative Warming Techniques in Reducing Intraoperative Blood Loss

August 15, 2014 updated by: Jie YI, Peking Union Medical College Hospital

Comparison of Active Warming System and Conventional Passive Warming Care in Reducing Intraoperative Blood Loss for Patients Undergoing Major Surgery

This is a randomized, open label, parallel two arm, clinical study, which compare the Bair Hugger forced-air warming blanket and the conventional warming care practice in China on patients undergoing major surgery to determine the impact of maintaining normothermia on intraoperative blood loss, requirement for transfusion of packed red blood cells and the changes of coagulation function.

Study Overview

Detailed Description

Each Investigator reviews the most current Instructions for Use for Bair Hugger Forced air Warming System to assess the contraindications, warnings, and precaution sections with respect to risks and benefits for treating potential patients.

60 patients will be enrolled preliminary in this clinical trial. Equal size of 30 patients were allocated randomly into interventional or control group.

Randomization will be performed after the patient has met all eligibility criteria, including the general inclusion or exclusion and the patient or legally authorized representative has signed an informed consent form prior to any study related procedure.

Prior to induction, patients in the interventional group were provided 15 to 30 minutes forced air warming using the Bair Hugger warming unit, either in the pre-anesthesia area or OR,which may add to the total heat content of the body helping to reduce the effects of redistribution temperature drop for procedures using a temperature management strategy. The Bair Hugger warming unit is placed on its highest temperature setting and will be adjusted by the investigator depending on temperature monitoring. Temperature will be measured in both groups by either Spot-On sensor and tympanic membrane thermometer.

Statistical analysis will be performed after the data of 30 cases (both groups) were available and the sample size will be re-estimated based on preliminary data analysis. Continuous variables will be summarized with mean, median, standard deviation, minimum and maximum, as applicable. Categorical variables will be summarized with frequency and percentage. Student t test will be used to compare means for continuous variables. A Chi square test or a Fisher's exact test will be used to compare proportions for categorical variables. Multiple regression will be performed to assess the risk ratios of patients developing hypothermia and will be expressed as an risk ratio along with a 95% confidence interval.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100000
        • Peking Union Medical College Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult patients≥18 years old
  • Preoperative core temperature between 36.0 and 37.5°C
  • American Society of Anaesthesiologists(ASA) Physical Status Classification System I-III
  • No transdermal meds on the target site
  • Elective major surgeries included but not limited:

    • Hip replacement
    • Thoracic surgery (lobectomy and esophagectomy) or abdominal surgery

Exclusion Criteria:

  • Less than 18 years old
  • Uncontrolled insulin-dependent diabetes mellitus (preoperative glucose >250 mg/dL)
  • A preoperative temperature above 37.5°C or less than 36°C
  • Hyperthyroidism and hypothyroidism
  • Raynaud disease
  • History of infection and fever within 4 weeks before surgery
  • Use of steroid or immunosuppressant within 4 weeks before surgery
  • History of bleeding disorders
  • Clinically significant laboratory abnormalities
  • Hgb ≤ 10.0 g/L
  • Platelets ≤ 100,000 / mL
  • WBC(white blood cell ) <3000/dL
  • Fibrinogen<200 mg/dL
  • Thromboplastin time>40s
  • Prothrombin time
  • international normalized ratio(INR)<70%

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Bair hugger forced air warming therapy
Use of Bair Hugger forced-air warming system perioperatively to keep patient normothermia
Bair Hugger Model 775 temperature management unit-offers two airflow settings, hose-end temperature sensing, and precise temperature delivery
Other Names:
  • Bair Hugger 775, 70-2007-6800
  • Bair Hugger Blanket Model 635 and 300
No Intervention: conventional warming care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Core Temperature and blood loss
Time Frame: intraoperative
Monitor the changes of core temperature for whole perioperative period and the amount of blood loss were recorded
intraoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of Stay in PACU
Time Frame: 90 days after Hip replacement surgery and 30 days after other surgerys
90 days after Hip replacement surgery and 30 days after other surgerys
Length of Stay in Hospital
Time Frame: 90 days after Hip replacement surgery and 30 days after other surgerys
90 days after Hip replacement surgery and 30 days after other surgerys
Length of Stay in ICU
Time Frame: 90 days after Hip replacement surgery and 30 days after other surgerys
90 days after Hip replacement surgery and 30 days after other surgerys
Surgical Site Infection(SSI)
Time Frame: 90 days after Hip replacement surgery and 30 days after other surgerys
90 days after Hip replacement surgery and 30 days after other surgerys
coagulation function
Time Frame: perioperative period
take blood sample to detect the coagulation function,including Prothrombin time,Active Partial Thromboplastin Time,International normalized Ratio,Thromboelastography,Hemoglobin,ect.
perioperative period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

3M

Investigators

  • Principal Investigator: Yugung Huang Huang, doctoral, Peking Union Medical College Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2014

Primary Completion (Anticipated)

November 1, 2014

Study Completion (Anticipated)

January 1, 2015

Study Registration Dates

First Submitted

August 8, 2014

First Submitted That Met QC Criteria

August 11, 2014

First Posted (Estimate)

August 12, 2014

Study Record Updates

Last Update Posted (Estimate)

August 18, 2014

Last Update Submitted That Met QC Criteria

August 15, 2014

Last Verified

August 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Blood Coagulation Disorders

Clinical Trials on Bair Hugger forced air warming system

Subscribe